Explainer: Inside Neimeth’s N1.98bn capital restructuring

Posted By: businessday
March 3, 2026

Neimeth International Pharmaceuticals Plc is seeking shareholder approval for a N1.98 billion capital restructuring that could significantly reshape its balance

read more Explainer: Inside Neimeth’s N1.98bn capital restructuring

Read actual content

Explainer: Inside Neimeth’s N1.98bn capital restructuring

Tags

Comment / Reply From

You May Also Like

Huawei connects 170 million people in remote areas, surpasses ITU digital inclusion target

Accion MfB deepens financial inclusion drive with new branch

Group rolls out initiatives to re-energise Bini-speaking people’s economy

Limited travel operations resume across the UAE

Bitget targets 40% of tokenized stock trading by 2030

Residents flee homes as ISWAP terrorists attack Yobe town

We’re in APC not to dislodge anyone, but to fortify the party — Fintiri

Least indebted states by debt stock as of September 2025

Popular Posts

Recent Posts

Recommended Posts

Nigeria’s New Tax Reforms: What Businesses, Youths, and Policymakers Need to Know

Featured Posts

Echoes of Horror: Kwara's Villages Wiped Out in Night of Terror

Popular Posts

Trump's Bold Move: Permanent Immigration Freeze on...

Africa's Power Battles: Coups Rise, Debts Mount, a...

Senate Approves Benin Troop Deployment - West Afri...

Editor Picks

Trump Warns Iran War Could Last Longer Than 4 Week...

AFCON Curse or Cowardice? Why Man United Walked Aw...

The Godfather’s Funeral: Nigeria’s Politics as a C...

Newsletter

Explainer: Inside Neimeth’s N1.98bn capital restructuring

Tags

Comment / Reply From

You May Also Like

Popular Posts

Stay Connected

Recent Posts

Recommended Posts

Featured Posts

Popular Posts

Editor Picks

Newsletter